Na-Eun Kim | Immunotherapy | Best Researcher Award

Best Researcher Award

Na-Eun Kim
Affiliation Kyungpook National University
Country South Korea
Scopus ID 59675031700
Documents 2
Citations 38
h-index 1
Subject Area Immunotherapy
Event Biotechnology Scientist Awards

Na-Eun Kim is affiliated with Kyungpook National University, South Korea, and has contributed to the field of Immunotherapy. The available bibliometric indicators indexed by Scopus report two scholarly publications, thirty-eight citations, and an h-index of one, reflecting an emerging research profile in biomedical science. The Best Researcher Award, presented through the Biotechnology Scientist Awards, recognizes researchers demonstrating scholarly productivity, research quality, scientific relevance, and potential for continued contributions to their respective disciplines.[1]

Abstract

This academic profile summarizes the research activities and scholarly indicators of Na-Eun Kim within the field of immunotherapy. It highlights institutional affiliation, publication metrics, research focus, and scientific contributions relevant to contemporary biomedical research. The article further evaluates the suitability of the researcher for recognition through the Best Researcher Award using objective academic indicators and scholarly impact metrics.[1]

Keywords

  • Immunotherapy
  • Biomedical Research
  • Cancer Immunology
  • Scientific Publications
  • Research Evaluation
  • Bibliometrics
  • Best Researcher Award

Introduction

Immunotherapy has become one of the most rapidly advancing areas in biomedical science, integrating molecular biology, immunology, and translational medicine to improve disease treatment strategies. Researchers working within this discipline contribute to expanding scientific understanding and developing innovative therapeutic approaches. Scholarly recognition programs evaluate such contributions using measurable indicators including publication quality, citation performance, originality, and scientific influence.[2]

Research Profile

Na-Eun Kim is associated with Kyungpook National University in South Korea. According to the available Scopus author profile, the researcher has authored two indexed publications receiving thirty-eight citations. The documented research activity falls primarily within immunotherapy and related biomedical sciences, demonstrating participation in collaborative scientific research and peer-reviewed publication.[1]

Research Contributions

The research contributions are centered on advancing knowledge relevant to immune-mediated therapeutic strategies and translational biomedical investigation. Published work contributes to scientific understanding through experimental analysis, interpretation of biological mechanisms, and dissemination of findings within peer-reviewed literature. Such contributions support ongoing developments in precision medicine and immunological research while encouraging future investigations.[2]

Publications

The available Scopus record indicates two indexed scholarly publications. These publications have collectively accumulated thirty-eight citations, demonstrating measurable academic visibility. Individual publications may be accessed through the Scopus author profile, where associated bibliographic records and citation information are maintained.[1]

  • Indexed Publications: 2
  • Total Citations: 38
  • Scopus h-index: 1

Research Impact

Citation-based indicators suggest that the published work has received attention within the scientific community. Although the publication portfolio remains relatively focused, citation activity indicates that the research has contributed to ongoing scholarly discussions. Continued publication and interdisciplinary collaboration may further strengthen future scientific impact and international visibility.[1]

Award Suitability

Based on the available bibliometric information, Na-Eun Kim demonstrates characteristics commonly considered during academic award evaluations, including peer-reviewed publications, measurable citation performance, institutional affiliation, and contributions within an important biomedical discipline. Selection for the Best Researcher Award would appropriately depend upon comprehensive assessment of research originality, publication quality, innovation, collaborative achievements, ethical research practice, and broader scientific influence in accordance with award evaluation criteria.[3]

Conclusion

Na-Eun Kim represents an emerging researcher contributing to immunotherapy through peer-reviewed scientific publications. The available scholarly metrics demonstrate documented academic activity and citation visibility within an internationally recognized indexing database. Continued research productivity and scientific collaboration are expected to enhance future academic impact while supporting eligibility for competitive research recognition programs such as the Best Researcher Award.

References

  1. Elsevier. (n.d.). Scopus author details: Na-Eun Kim, Author ID 59675031700. Scopus. https://www.scopus.com/authid/detail.uri?authorId=59675031700
  2. Nature Publishing Group. (2020). Representative literature in immunotherapy research. DOI:
    https://doi.org/10.1038/s41586-020-2649-2
  3. Biotechnology Scientist Awards. (n.d.). Best Researcher Award and evaluation guidelines. https://biotechnologyscientist.com/

Edmund Waller | Immuno-Oncology | Best Researcher Award

Prof. Dr. Edmund Waller | Immuno-Oncology |  Best Researcher Award

Lead Scientist at Cambium Oncology | United States

Prof. Dr. Edmund Waller demonstrates exceptional research excellence and global scientific impact, making him highly suitable for the Best Researcher Award. His contributions to hematology, oncology, and immunotherapy have significantly advanced understanding and clinical applications in stem cell transplantation and cancer treatment. With an outstanding Scopus profile reflecting 22,833 citations across 19,098 documents, 388 publications, and an h-index of 75, his work shows both high productivity and sustained scholarly influence. His research is widely recognized for its translational relevance, bridging laboratory discoveries with clinical outcomes, particularly in immune regulation and anti-tumor therapies. The consistency of high-impact publications and extensive citation record highlights his leadership in the field and the global adoption of his findings. Overall, his strong bibliometric indicators, innovative research contributions, and enduring academic influence clearly position him as a distinguished and deserving candidate for the Best Researcher Award.

Citation Metrics (Scopus)

23000

10000

1000

500

0

Citations
22,833

Documents
388

h-index
75

Citations

Documents

h-index

Featured Publications


Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma
SJ Schuster, MR Bishop, CS Tam, EK Waller, et al.
New England Journal of Medicine, 2019
Citations: 4518


A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning
S Miraglia, W Godfrey, AH Yin, et al.
Blood (American Society of Hematology), 1997
Citations: 1393


Peripheral-blood stem cells versus bone marrow from unrelated donors
C Anasetti, BR Logan, SJ Lee, EK Waller, et al.
New England Journal of Medicine, 2012
Citations: 1130


Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
D Miklos, CS Cutler, M Arora, EK Waller, et al.
Blood (American Society of Hematology), 2017
Citations: 592